Follow the KALA BIO, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €14.5m. The latest transaction was reported on 24 October 2025 (Cession). Among the most active insiders: Iwicki Mark T. Every trade is openly available.
52
Insider Decl.
n/a
Thresholds
€2m
2 ops.
Buy Volume
€684,821
27 ops.
Sell Volume
40Σ signal
Buys €2m€684,821 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
KALA BIO, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades oculares. Cotiza en NASDAQ bajo el ticker KALA.